4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000155
Chairperson & CEO sold 9,500 shares at an average $576.47 ($5,476,462)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
20 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-01 | Sale : show line 2 in the form 10b5-1 | −120 | $560.05 | $67,206 | 333,823 | I |
| 2026-10-01 | Sale : show line 3 in the form 10b5-1 | −80 | $561.68 | $44,934 | 333,743 | I |
| 2026-10-01 | Sale : show line 4 in the form 10b5-1 | −160 | $563.31 | $90,130 | 333,583 | I |
| 2026-10-01 | Sale : show line 5 in the form 10b5-1 | −94 | $567.90 | $53,383 | 333,489 | I |
| 2026-10-01 | Sale : show line 6 in the form 10b5-1 | −306 | $569.65 | $174,314 | 333,183 | I |
| 2026-10-01 | Sale : show line 7 in the form 10b5-1 | −534 | $570.55 | $304,673 | 332,649 | I |
| 2026-10-01 | Sale : show line 8 in the form 10b5-1 | −320 | $571.52 | $182,888 | 332,329 | I |
| Open-market sales · 9,500 sh · avg $576.47 · $5,476,462 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-01 | Exercise or conversion : show line 21 in the form 10b5-1 Stock Option | −9,500 | 318,910 | I |
Loading xslF345X06/primarydocument.xml…